Lymphodepletion-free jl-lightning CAR-T targeting CD19/CD22/BCMA achieved 100% CR in 3 Relapsed/Refractory B-NHL patients: A lymphodepletion regimen comparison study
Jinxing Lou(Shanghai University), Qijun Qian(Shanghai University), Xinhong Guan(Shanghai University), Lijie Rong(Shanghai Cell Therapy Research Institute), Hongfan Zhu(Shanghai Cancer Institute), Zhi‐Feng Miao(Kaohsiung Medical University), Shuya Wang(Central South University), Wenfeng Xu(Vyne Therapeutics (United States)), Yi Liu(China National Building Materials Group (China)), Zhicai Lin(Shanghai Cell Therapy Research Institute), Yan Gao(North China University of Science and Technology), Mengxin Xia(Shanghai University of Traditional Chinese Medicine), F. C. Ma(Shanghai Cell Therapy Research Institute), Yan Sun(Tianjin Medical University General Hospital)
Cited by 0
Related Papers
Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion
|Nature Communications|2017|268
Regenerative proliferation of differentiated cells by mTORC1‐dependent paligenosis
|The EMBO Journal|2018|207
MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1
|Oncogene|2011|187
Adipocyte iron regulates leptin and food intake
|Journal of Clinical Investigation|2015|122
Potent Antitumor Activity of Oncolytic Adenovirus Expressing mda-7/IL-24 for Colorectal Cancer
|Human Gene Therapy|2005|111